Clinical Trials Update: Sept. 15, 2006
Psychosis Ulcerative Colitis Non-Small Cell Lung Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This research study will test a new medication to treat opiate withdrawal. You may be eligible if you are physically dependent on opioids (i.e. Oxycodone, Lortab or Vicodin), 18 years and older, and willing to undergo detoxification in the hospital for up to eight days. Participation in the study is free and will include medical screenings, meals, and snacks.
The research site is in Lexington, Ky.
Volunteers 18 or older with a history of mild-to-moderate active ulcerative colitis and symptoms of acute flare within the past four weeks may be eligible for this clinical trial. People may not participate if they have had bowel surgery, HIV, Hepatitis C or B, cancer within the past five years, unstable cardiovascular history, or renal disease. There is a stipend of up to $400.
The research site is in DeLand, Fla.
Non-Small Cell Lung Cancer
This is a randomized trial of Paclitaxel, Carboplatin and Bevacizumab with or without the study drug for people with advanced nonsquamous non-small cell lung cancer. Candidates with histologically/cytologically-confirmed NSCLC except squamous cell may be included. Additional criteria apply.
The research site is in Beech Grove, Ind.
Copyright 2006 Thomson CenterWatch. All rights reserved.